Displaying 1 - 5 of 5
| Active Ingredient | ABSORBABLE GELATIN |
| Therapeutic Class | HEMOSTATICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | AMINOCAPROIC ACID |
| Therapeutic Class | HEMOSTATICS |
| Indications | Increase Fibrinolysis. |
| Caution | Allergic reactions, chills, fever. |
| Dose Range |
Initial priming dose 4-5g during the first hour, followed at 1 hour intervals of 1-1.25g. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FACTOR IX |
| Therapeutic Class | HEMOSTATICS |
| Indications | Treatment of Hemophilia B. |
| Caution | Hypersensitivity reactions. |
| Dose Range | Depends on the desired increase in plasma IX levels. To calculate dose take body weight in kg multiplied by 1iu/kg multip lied by the desired increase in plasma factor IX. |
| Drug Interactions | |
| Pregnancy | Use only if clearly needed. |
| Breast Feeding |
| Active Ingredient | FACTOR VIII |
| Therapeutic Class | HEMOSTATICS |
| Indications | Treatment of Hemophilia A. |
| Caution | Some patients develop antibodies. |
| Dose Range |
The dosage of factor VIII should be determined for each patient and will vary with the circumstances involving bleeding. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FIBRINOGEN HUMAN |
| Therapeutic Class | HEMOSTATICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |